<DOC>
	<DOCNO>NCT00002156</DOCNO>
	<brief_summary>To determine clinically safe effective dose intravitreal ISIS 2922 alone additive antiviral therapy ganciclovir AIDS patient cytomegalovirus ( CMV ) retinitis .</brief_summary>
	<brief_title>A Randomized Comparison Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir Treatment Patients With Cytomegalovirus Retinitis ( CMVR )</brief_title>
	<detailed_description>In Stage 1 study , 20 patient receive one two dos ISIS 2922 day 1 , 8 , 15 ( Induction ) every 14 day ( maintenance ) , ganciclovir give daily Induction Maintenance . Escalation second dose occur patient first dose level reach first maintenance dose ( day 29 ) . In Stage 2 study , 174 patient randomize receive either ) ISIS 2922 dose establish Stage 1 day 1 , 8 , 15 every 14 day , ganciclovir give daily Induction Maintenance , b ) ganciclovir daily 14 consecutive day low dose maintenance . Patients may continue receive ISIS 2922 biweekly dose safe CMV retinitis clinically control . Per 2/8/96 amendment , patient Stage 2 150 mcg .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Fomivirsen</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Patients must : AIDS . CMV retinitis adequately control ( previously diagnose patient smolder CMV retinitis active CMV retinitis border indirect ophthalmoscopy ) . No one previous progression CMV retinitis . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition eye treat exclude : External ocular infection . Other herpetic infection retina , toxoplasma retinochoroiditis , disease fundus . Ocular condition obstruct visualization posterior ocular structure . Retinal detachment . Silicone oil eye . Patients follow symptoms condition exclude : Known suspect allergy phosphorothioate oligonucleotides . Syphilis . Retinal pigment epithelial stippling associate CMV retinitis . Pseudoretinitis pigmentosa . Chronic diarrhea would impair absorption oral ganciclovir . Intolerance ganciclovir . Concurrent Medication : Excluded : Foscarnet antiCMV agent ganciclovir . Mellaril . Stelazine . Thorazine . Clofazimine . Ethambutol/fluconazole combination . Investigational medication CMV retinitis . Concurrent Treatment : Excluded : Investigational procedure CMV retinitis . Patients follow prior condition exclude : History surgery correct retinal detachment eye treat . History intolerance ISIS 2922 . Prior Medication : Excluded : Prior ganciclovir implant CMV retinitis . More 4 month prior ganciclovir .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1998</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Cytomegalovirus Retinitis</keyword>
	<keyword>Injections</keyword>
</DOC>